0xmd Partners with SENAI CIMATEC to Launch Operations in Brazil
HONG KONG SAR - Media OutReach Newswire - 12 May 2025 - 0xmd, a global startup specializing in Generative Artificial Intelligence for healthcare, has entered into a strategic partnership with SENAI CIMATEC, one of Brazil's leading technology and innovation institutions. This agreement marks the beginning of 0xmd's operations in Brazil, expanding the company's presence in the Latin American market.
The collaboration will see 0xmd bring its cutting-edge AI technologies to Brazil, including solutions for automated clinical exam analysis, medical image interpretation, and conversational diagnostic support. This partnership positions 0xmd as the first international healthtech to integrate with CIMATEC's innovation ecosystem.
With existing operations in the United States and China, 0xmd aims to contribute to the democratization of healthcare access in Brazil by providing intelligent tools that support medical professionals in diagnosis, treatment planning, and personalized care. A key differentiator of 0xmd's technology is its use of medical and healthcare large language models with natural language interfaces, such as clinical chatbots, that facilitate seamless interaction between healthcare providers and decision-support systems.
'Partnering with SENAI CIMATEC enables 0xmd to localize its solutions for the Brazilian market and scale its impact in the region,' said Allen Au, Chairman & Chief Architect of 0xmd. 'SENAI CIMATEC's strong reputation in innovation and research makes it an ideal partner to help us navigate the Brazilian healthcare landscape and ensure the successful integration of our technology.'
The initial phase of the project will focus on adapting 0xmd's technology to Brazilian regulations and integrating with local healthcare systems. The partnership also aligns with the growing demand for AI solutions in the healthcare industry, particularly in areas such as image-based diagnostics, clinical report automation, and personalized therapies.
The partnership with SENAI CIMATEC reinforces 0xmd's commitment to expanding its global impact and driving innovation in healthcare.
Hashtag: #0xmd
The issuer is solely responsible for the content of this announcement.
About 0xmd
0xmd Inc. is a pioneer in Generative AI healthcare solutions platform based in Hong Kong China and the US, specializing in Large Language Models (LLMs) and Large Visual Language Models (LvLMs) designed for medical applications. 0xmd is capable of providing 24/7 online diagnostic support that integrates both Western Medicine and Traditional Chinese Medicine, automation of clinical exam analysis, medical image diagnostics, as well as total health management solutions. The company is dedicated to transforming the healthcare landscape by optimizing healthcare systems, in order to make healthcare resources more equitable and accessible.
https://www.0xmd.com
About SENAI CIMATEC
SENAI CIMATEC is Brazil's leading technology and innovation center, comprising a Technological Center, a University, and a Technical School that operate in synergy. Established in 2002, it is a private, non-profit institution dedicated to Research, Development, and Innovation (RD&I), focusing on delivering advanced solutions to the industry. With expertise in 43 areas—including robotics, quantum computing, AI, energy, and sustainability—SENAI CIMATEC is committed to driving technological advancements to meet the evolving market needs. The institution develops and implements projects with national and international impact, collaborating with renowned institutions and partners worldwide.
https://linktr.ee/senaicimatec_oficial
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
LQpay Expands Compliant Surcharging Solution, Optimizing Payment Strategy for Healthcare Practices
End-to-End Compliant Credit Surcharging with Custom Integration Now Available PLANTATION, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- LQpay, a leading provider of innovative patient payments and automation technology, announced the expansion of its end-to-end compliant credit card surcharging solution, empowering healthcare practices to optimize their payment strategy and more seamlessly defray operational costs without sacrificing efficiencies or the patient experience. The latest enhancements enable medical and dental organizations to pass along credit card processing fees and serve up the necessary disclosures to patients across all eligible channels, encompassing both in-office and remote payment types, such as recurring billing plans, text- and email-to-pay, card on file, etc. In addition, by leveraging its proprietary RPA (Robotics Processing Automation) technology, LQpay has the unique capability to customize the integration of these payment types into any underlying EMR/practice management system. This custom integration capability allows practices to tailor the posting and reporting of surcharged transactions according to their unique workflows, business requirements, and practice management systems. By automatically calculating and applying compliant surcharges to eligible credit card transactions and facilitating accurate record-keeping of patient accounts, healthcare practices can reduce operational expenses without increasing administrative burden. As payment processing costs continue to rise, healthcare providers face continuous pressure on operating margins. LQpay's enhanced surcharging platform offers a powerful, compliant way for practices to offset these expenses without disrupting workflows or compromising the patient experience. 'Today's healthcare practices need more than a payment processor. They need a partner who can help them navigate complexity while protecting profitability,' said Shashi Kapur, CEO of LQpay. "Based on valuable feedback from our customers and partners, along with our dedication to innovation, we are proud to be a premier payments technology provider merging end-to-end compliant surcharging with robust Robotics Processing Automation (RPA). Our expanded surcharging capabilities provide healthcare organizations with a turnkey, compliant way to reduce costs and operate more efficiently.' Since its initial introduction, LQpay's compliant surcharging feature has provided practices with a valuable tool to offset the growing expense of payment processing fees. Recognizing the evolving needs of the healthcare industry and LQpay's commitment to continuous improvement, these enhancements truly set LQpay apart in the industry, ensuring practices experience greater efficiency and maximized financial benefit. Key Benefits of LQpay's Surcharging Enhancement: Optimized payment strategy ensuring credit card processing fees are consistently offset, regardless of how patients choose to pay. Custom integration with practice management systems (PMS). Unlike generic surcharge options, payments are automatically posted according to each practice's workflow and reporting requirements. Certified, compliant solution aligned with processor mandates, card network rules, and applicable state and regional regulations. Configurable patient communications and transparent fee disclosures to ensure patients are clearly informed about surcharges before payment and provided options for alternative, non-surcharge payment methods (e.g., ACH, debit, cash). Real-time reconciliation and reporting tools with detailed dashboard, making it easy to track surcharge revenue and monitor compliance without manual record-keeping. The surcharging capability is now available to both new and existing LQpay customers using approved payment gateways. Practices eager to enhance their financial performance and reduce processing expenses are encouraged to schedule a personalized demonstration. About LQpay Based in Plantation, FL, LQpay stands as a leading end-to-end patient payments platform, dedicated to serving the healthcare, dental, and veterinary practices. By integrating cutting-edge automation, AI-powered integrations, and modern payment functionalities such as text-to-pay and auto-posting, LQpay empowers practices to streamline operations, accelerate cash flow, and elevate the overall patient financial experience. For more information or to schedule a demo, please visit CONTACT: Press Contact: 954.909.5948 info@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
43 minutes ago
- Yahoo
Invitation for Interest to Participate for Development of the HKSTP San Tin Technopole
HONG KONG, June 11, 2025 /PRNewswire/ -- CBRE has been appointed by Hong Kong Science and Technology Parks Corporation (HKSTP) as the lead consultant for the business, operation and investment models of the HKSTP San Tin Technopole (working title). CBRE will invite interested property developers and consortia to submit its Interest to Participate (ITP) for the development. The deadline for ITP submissions is set for 12:00 noon, June 21, 2025. As part of the Northern Metropolis development, the broader San Tin Technopole, encompassing over 600 hectares, will have half of its area to be designed for innovation and technology (I&T) use. This translates into 7 million sq.m. of gross floor area for research & development, prototyping, pilot testing, and advanced manufacturing. The project led by Hong Kong Science and Technology Parks Corporation (HKSTP) at the San Tin Technopole, will be developed on 20 hectares of government-granted land, with construction set to begin in 2027. As outlined in the 2024 Policy Address, the government aims to deliver approximately 20 hectares of new innovation and technology (I&T) sites in phases, starting from 2026–27, for HKSTP's development and operation. Strategically located near Shenzhen, the development is designed to complement Shenzhen's I&T zones in Huanggang and Futian, forming a synergistic innovation hub. It will become a comprehensive I&T ecosystem, catalysing growth in sectors such as AI and data science, life and health tech, new material/energy, microelectronics/electronics and advanced manufacturing. Hannah Jeong, Executive Director, Valuation and Advisory Services, CBRE Hong Kong said: "While the entire San Tin Technopole is envisioned as a major driver of Hong Kong's new industrialisation and a second economic engine in the North complementing the established financial engine in the South (CBDs), this development represents a rare opportunity to shape a world-class innovation powerhouse, particularly for artificial intelligence, advanced manufacturing, biotech, and green tech. We are laying the foundation for a new era of industrialisation, offering space and infrastructure for R&D, prototyping, and pilot production." Hannah added: "This is not just a development—it's a bold vision for the future of innovation. Backed by HKSTP's proven track record, the development is poised to become a dynamic I&T ecosystem and a global launchpad for innovation, especially in today's fast-evolving, AI-driven era. Leveraging CBRE's extensive client network, deep expertise in commercial real estate and land advisory, and its regulatory credentials—including SFC Type 1 and Type 4 licenses, as well as an EAA license—we are excited to support private investors and developers in exploring the tremendous opportunities this project offers. We invite them to share their perspectives in shaping a win-win public-private partnership model, with strong potential for attractive investment returns and long-term capital appreciation." For any additional details, please contact Ms Hannah Jeong, Executive Director (Email: Tel: +852 2820 2818), or Mr. Eddie Tsui, Senior Director, (Email: Tel.: +852 2820 2845) of Valuation and Advisory Services, CBRE Hong Kong. Follow us on Instagram: cbre_hongkongAnd on LinkedIn: company/cbre-asia-pacific DISCLAIMER:Neither CBRE nor its affiliated companies make any warranties or claims on the express or implied accuracy of the information contained herein. All information contained herein, including projections, has been obtained from materials and sources which we believe to be reliable at the date of publication but which we have not verified its accuracy and make no guarantee, warranty or representation about it., and is not to be used or considered as an offer or the solicitation of an offer to sell or buy or subscribe for securities or other financial instruments. Readers are responsible for independently assessing the relevance, accuracy, completeness and currency of the information of this report. It is submitted subject to the possibility of errors, omissions, change of price, rental or other conditions, prior sale, lease or financing, or withdrawal without notice. You are advised to conduct your own assessment, property inspection and measurement, and/or seek advices from your independent professional advisors. CBRE shall not be liable for any loss, damage, cost or expense incurred or arising by reason of any person using or relying on information in this report. All rights to the materials are expressly reserved and none of the materials, nor their content, nor any copy of it, may be altered in any way, transmitted to, copied or distributed to any other party without the prior express written permission of CBRE. For any information of or relating to floor area, readers should note that there is no standardized or commonly adopted definition of any description of floor area in the market for non-residential properties. About CBRE Group, Group, Inc. (NYSE:CBRE), a Fortune 500 and S&P 500 company headquartered in Dallas, is the world's largest commercial real estate services and investment firm (based on 2024 revenue). The company has more than 140,000 employees (including Turner & Townsend employees) serving clients in more than 100 countries. CBRE serves a diverse range of clients with an integrated suite of services, including facilities, transaction and project management; property management; investment management; appraisal and valuation; property leasing; strategic consulting; property sales; mortgage services and development services. Please visit our website at View original content to download multimedia: SOURCE CBRE Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
44 minutes ago
- Yahoo
‘I had to sprint home from a first date': the truth about romance during hay fever season
It's 3pm on a warm early summer's day. You're in the park, a picnic basket beside you, watching your date tuck into an ice-cream. Birds are singing, children are chuckling playfully nearby. Things are going well: your date's handsome, kind and the conversation is good. But something's wrong. It starts as a tickle in the back of the throat. Then your eyes start itching and soon your nose is streaming. Suddenly, you're sneezing uncontrollably and, hang on, are you … crying? The date you're with looks at you sympathetically – poor thing – and you quietly wish for the ground to swallow you up. It's not an uncommon scenario. In the UK, it's estimated that about 10 million people suffer from hay fever. Whenever we hit a patch of extended sunny weather, it's often caveated with warnings of impending so-called 'pollen bombs', when lots of plants release more pollen than usual all at the same time. While the warmer climes are welcome (and perfect date weather), this also means that if you're a hay fever sufferer, life is about to get complicated. But what's actually happening when you're struck by an attack? 'Your immune system produces an allergic antibody that is specific to the things you are allergic to – in this case, pollen,' says Prof Adam Fox, one of the UK's leading specialists in allergies. 'It circulates in your blood and attaches to cells called 'mast cells' in the lining of the nose, mouth and eyes. When you breathe in pollen, it's recognised by these antibodies and it sticks to them – the mast cell then releases granules of histamine stored inside it.' This is, of course, usually expelled as a sneeze – something which has, amusingly, been regarded suspiciously throughout history (in the middle ages people thought a sudden sneeze was a warning that you were close to evil, while in Japan and China it's thought that if you sneeze randomly, it means someone is talking about you). 'I have a very full-on sneeze,' says Hannah Lyons, 30. 'It's loud and often goes on and on – I'll have 10 sneezes in a row, particularly if hay fever is the cause. I often find myself apologising after a sneezing fit. It's embarrassing! I've had hay fever for the last five years or so – it came on suddenly one summer and I was shocked by just how debilitating it can be. I have to wear sunglasses outside in the spring and summer now or my eyes get unbearably itchy.' Hay fever-proofing doesn't just extend to eyewear for Hannah, who is single, but her dating life, too. 'I once had a sneezing fit so bad on a date that I had to go home,' she says. 'It might sound trivial but it does properly impact my life when it's bad. The guy I was with at the time of the fit had never had hay fever, so he just looked at me like I was mad, while I couldn't stop sneezing. I eventually – between sneezes – told him I needed to go home to get inside and ran off. We didn't see each other again.' If you're a hardcore hay fever sufferer, then precautions, particularly when it comes to dating and meeting new people, are standard. 'It's tricky,' says Katie*, 32. 'I'm in an open relationship and last summer was my first time properly dating in that way. I was due to meet up with a date and because I suffer so badly with hay fever, and have done since I was a kid, I warned her beforehand. I wrote her a proper message to say that my eyes might end up bloodshot and teary at some point – we were grabbing coffee and going for a walk in a park, so I think she was quite baffled. As expected, I did end up with weepy eyes. We went on a few more dates before we decided to stay just friends and it ended up becoming a running joke that I was always 'crying'.' This year, Katie has beefed up her hay fever precautions. 'I have an air filter in my bedroom and I'll be keeping all the windows shut and running the fan throughout the summer. If I can manage my hay fever in my flat, I feel I'm better equipped to manage it outside too. When the pollen count is high, I tend to use a nasal spray each day, regardless of whether I'm feeling symptoms or not**. If you're dating outside – which I plan to this summer – it really is something you have to think about.' Similarly, Hannah is taking action to try to alleviate any symptoms and has recently started using a spray. 'I use Beconase specifically – it can work even better if you start using it before the pollen count is super high**. I often think if I'd had a nasal spray I might not have had to sprint away from that first date. 'With a brand new summer, one hopefully filled with dates, not having to worry as much about hay fever symptoms feels joyful. And isn't that how dating is supposed to feel?' * not her real name Buy Beconase now on Amazon Beconase Hayfever Relief for Adults 0.05% Nasal Spray contains beclometasone dipropionate. For the treatment of hayfever in adults aged 18 and over. Always read the leaflet. ** Beconase Hayfever contains beclometasone dipropionate. For the prevention and treatment of allergic rhinitis, including hayfever, in adults aged 18 and over. Always read the leaflet. Disclaimer: Prof Adam Fox does not endorse Beconase
